A switch from compounded GLP-1s to branded drugs like Wegovy, plus write-downs and one-off costs, hit results and sent shares lower as the company targets profitability in 2027
Farahzadi R, Sanaat Z, Movassaghpour-Akbari AA, Fathi E, Montazersaheb S
By End User: Direct consumers are forecast to hold 43.9% share in 2026 as users begin care when treatment intent is high
oral supplementation within a comprehensive formulation like Ventamin Light Up represents a regulatory-compliant alternative
While glutathione is our bodies most abundant antioxidant, it also depletes quickly once youve been exercising for over an hourso endurance athletes might find it beneficial to supplement
The FDA continues to evaluate many of these compounds for compounding safety, which further underscores the importance of working with a credentialed clinic